VoctoR Health is a digital neurohealth company developing AI-driven VR/XR platforms to objectively assess brain function and support personalised care across neurodegenerative diseases, neuropsychiatric disorders, and neurorehabilitation.
The platform is built around structured VR-based tasks and game-like experiences in which individuals interact naturally while performing goal-oriented activities. During these tasks, hand, head, and eye movements are continuously captured alongside in-game performance data such as accuracy, timing, error patterns, and task completion dynamics. This combination enables simultaneous measurement of behaviour, motor control, attention, and cognitive-motor integration within an ecologically valid digital environment.
These multimodal signals are processed through explainable artificial intelligence (XAI) models to derive digital biomarkers and neuromarkers that reflect underlying neurofunctional states, such as attention regulation, executive control, visuospatial processing, motor coordination, and spatial navigation. The XAI framework is designed to ensure transparency by linking model outputs to interpretable behavioural and performance features, supporting clinical understanding and trust.
The company has developed five modular product lines targeting ADHD, Alzheimer’s disease, Mild Cognitive Impairment (MCI), depression, and neuro rehabilitation. Each product is built upon a shared digital biomarker and AI engine, allowing scalable deployment across multiple clinical domains while preserving disease-specific clinical relevance.
VoctoR Health holds six secured patents covering digital biomarker generation, multimodal sensor fusion, and AI-based behavioural modelling. The organisation has completed multiple competitively funded TÜBİTAK R&D projects and maintains active international academic collaborations with leading universities and clinical research groups. Through its research-driven development model, VoctoR Health contributes to the advancement of next-generation digital health tools that enable objective, scalable, and earlier assessment and personalised support across neurodegenerative, neuropsychiatric, and neurorehabilitation settings.